Table 1.

List of AML patients׳ bone marrow and blood samples used.

Patient number	Sample type (PB/BM)	AML type	Remarks
1	BM	Refractory cytopenia with excess of blasts II (15%), normal karyotype, FLT3 positive	Palliative care
2	BM, PB	Acute myeloid leukemia with multilineage dysplasia, complex karyotype, FLT3 negative	Treatment: clofarabine-refractory
3	BM	Acute myeloid leukemia normal karyotype, FLT3 positive	Treatment: daunorubicin and cytarabine – complete remission
4	BM, PB	Acute myeloid leukemia, not otherwise categorized, Acute myeloid leukemia without maturation, normal karyotype, FLT3 negative	Treatment: daunorubicin and cytarabine – refractory

Note: samples were received upon diagnosis.